{"id":"W4415665469","doi":"10.51731/cjht.2025.1274","title":"Mirvetuximab Soravtansine (Elahere)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Fallopian tube; Cancer; Disease; Fallopian tube cancer; Primary care; Drug; First line","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004037884,0.0001790727,0.0002996138,0.0004957377,0.0003122879,0.0004904818,0.0003740225,0.0005226503,0.01885192],"category_scores_gemma":[0.0006419925,0.0001082837,0.0003280143,0.0003017655,0.0001799794,0.0002283242,0.0003577566,0.001022327,0.004388897],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002047964,"about_ca_system_score_gemma":0.002293712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02487055,"about_ca_topic_score_gemma":0.07846957,"domain_scores_codex":[0.9997135,0.00003574944,0.0000152942,0.00003518653,0.000150667,0.00004967452],"domain_scores_gemma":[0.9997444,0.0000254002,0.00003630726,0.00001466077,0.00008302164,0.00009620022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001658547,0.0003061197,0.00275765,0.000641504,0.00008921855,0.0004421099,0.00004588458,0.0005133745,0.009434256,0.005121832,0.1897965,0.7891929],"study_design_scores_gemma":[0.001059047,0.0008386334,0.009007496,0.0002258818,0.0000527035,0.001461422,0.00001874228,0.0004918008,0.004010062,0.0005388996,0.9822809,0.00001452091],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.1084814,0.1743586,0.006428633,0.03425128,0.003310359,0.0009605265,0.01056351,0.003098142,0.6585473],"genre_scores_gemma":[0.6021245,0.05525381,0.01352798,0.01682149,0.0007917512,0.0003694401,0.01471801,0.0002122568,0.2961809],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.997952,"threshold_uncertainty_score":0.06306601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02888570688514977,"score_gpt":0.3440581177649768,"score_spread":0.3151724108798271,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}